EECP Therapy
A group for EECP Therapy providers or those interested in the technology and becoming a provider.
A Professional & Personal Networking Site for all People related to Cardiology
-
Paul Persaud
- Male
- Westbury, NY
- United States
- Blog Posts
- Discussions (2)
- Cardiology Events
- Groups (1)
- Cardiology Images
- Cardiology Albums
- Cardiology Videos (3)
Paul Persaud's Discussions
Latest Study Provides Evidence Confirming the Mechanism of Action of Vasomedical’s EECP Therapy in Treating Cardiovascular Disease
Vasomedical, Inc. (“Vasomedical”) (OTC: VASO.OB), a world leader in the noninvasive treatment of cardiovascular diseases, today announced the online publication, on October 4, 2010 in the journal…Continue
Tags: randomized, controlled, study, ccs, failure
Started Mar 15, 2011
EECP as an effective treatment for heart failure and
There are 5.7 million heart failure (HF) patients in the United States, 10 million in Europe and 20 million in Asia. In the US, 670,000 new patients are diagnosed with HF, with 12-15 million office…Continue
Tags: external, counterpulsation, statistics, agina, healthcare
Started Dec 23, 2009
Gifts Received
Paul Persaud has not received any gifts yet
Paul Persaud's Page
Latest Activity
ASHUTOSH VASHISTHA commented on Paul Persaud's group 'EECP Therapy'
PIONEERING EECP THERAPY IN LUCKNOW ,UP,INDIA
Vasomedical EECP Inside Business Video Segment
5-Minute Segment From CNN Headline News' Inside Business On Vasomedical's exclusive EECP Therapy. EECP Therapy is an oupatient treatment for angina and heart...
Video posted by Paul Persaud
Vasomedical to Exhibit at ACC.11, April 2-5, 2011 in New Orleans, LA! Read more here: http://ning.it/gh3349
Status posted by Paul Persaud
Latest Study Provides Evidence Confirming the Mechanism of Action of Vasomedical’s EECP Therapy in Treating Cardiovascular Disease
Vasomedical, Inc. (“Vasomedical”) (OTC: VASO.OB), a world leader in the noninvasive treatment of cardiovascular diseases, today announced the online publication, on October 4, 2010 in the journal Circulation, of new evidence confirming improved endothelial function in patients with symptomatic coronary artery disease, in a randomized, sham-controlled clinical trial conducted by a well known cardiology group at the University of Florida in Gainesville. The Florida group led by Dr. Randy Braith…See More
Discussion posted by Paul Persaud
Paul Persaud updated their profile
Paul Persaud updated their profile photo
EECP Therapy
A group for EECP Therapy providers or those interested in the technology and becoming a provider.
DR.BASIL SHAMMA joined Paul Persaud's group
EECP as an effective treatment for heart failure and
There are 5.7 million heart failure (HF) patients in the United States, 10 million in Europe and 20 million in Asia. In the US, 670,000 new patients are diagnosed with HF, with 12-15 million office visits and 6.5 million hospital days each year. In the United States, the total inpatient and outpatient costs for HF in 2005 were approximately $37.2 billion with an additional $3 billion spent annually onHF treatment drugs...Learn about how EECP can treat heart failure, billing for EECP and its…See More
Discussion posted by Paul Persaud
Paul Persaud commented on Paul Persaud's video
This is a video on how EECP Therapy works. Please leave your comments and for more information visit www.vasomedical.com
EECP Therapy
A group for EECP Therapy providers or those interested in the technology and becoming a provider.
Group posted by Paul Persaud
Profile Information
- Current Organization/Hospital
- Vasomedical, Inc.
- Profession
- Cardiovascular Technologist, Industry Leader, Representative of a Professional Organization
- Title of your Job
- Marketing Manager
- Clinical, Academic, Business & Research Interests in Cardiology
- Vasomedical, Inc. is primarily engaged in designing, manufacturing, marketing and supporting EECP® external counterpulsation systems based on the Company's proprietary technology. EECP® therapy is a non-invasive, outpatient therapy for the treatment of diseases of the cardiovascular system currently indicated for use in cases of angina, cardiogenic shock, acute myocardial infarction and congestive heart failure. The therapy serves to increase circulation in areas of the heart with less than adequate blood supply and may restore systemic vascular function. The Company provides hospitals, clinics and private practices with EECP® equipment, treatment guidance and a staff training and maintenance program designed to provide optimal patient outcomes. EECP® is a registered trademark for Vasomedical's enhanced external counterpulsation system. Through its agreement with GE Healthcare, the Company is also engaged as an exclusive sales representative for certain GE Healthcare products. VasoHealthcare™, a wholly owned subsidiary of Vasomedical Inc. is a professional sales representation company offering vendors an alternative third party sales channel. Additional information is available on the Company's website at www.vasomedical.com.
- Current Subspeciality in Cardiology
- Angina & Congestive Heart Failure
- Articles Published
- www.vasomedical.com
- Professionally Interested in
- new ventures, just sharing cardiology knowledge
- Personally Interested in
- professional networking, business networking
- My Website
- www.vasomedical.com
Paul Persaud's Cardiology Videos
-
-
-
How EECP Therapy Works
Added by Paul Persaud
Comment Wall
- No comments yet!
